|
J. Biol. Chem., Vol. 263, Issue 18, 9040-9049, 06, 1988
Role of glycosylation for beta 2-adrenoceptor function in A431 cells
F Boege, M Ward, R Jurss, M Hekman and EJ Helmreich
Department of Physiological Chemistry, University of Wurzburg Medical School, Federal Republic of Germany.
A431 cells incubated with tunicamycin (0.15 micrograms/ml) for 40 h under
conditions where incorporation of [3H] leucine into protein was inhibited
less than 10% expressed mainly a beta-receptor species of about Mr 40,000
which was ascribed to the nonglycosylated form of the beta-receptor of
about Mr 75,000 found in normal A431 cells by photoaffinity labeling.
However, the tunicamycin-treated cells expressed the same number of
specific beta 2-receptor-binding sites as untreated cells. Moreover, the
aglycoreceptors had the same ligand binding properties as
beta-adrenoceptors from control cells; but, functional tests of the
receptor from tunicamycin-treated cells in reconstituted lipid vesicles
showed that receptors from tunicamycin- treated cells had lost coupling
efficiency. The coupling defect was at the receptor level since control
experiments indicated that the other components of the signal transmission
chain from beta-adrenoceptor to adenylate cyclase, the stimulatory
regulatory GTP-binding protein of adenylate cyclase and adenylate cyclase,
were fully functional. Homologous desensitization in tunicamycin-treated
cells was characterized by export from the cell surface and sequestration
of about the same number of beta-adrenoceptors as in normal desensitized
cells but without further reduction of hormonally stimulated adenylate
cyclase below the low level already attained in nondesensitized
tunicamycin-treated cells. This was explained by assuming that the
receptors removed in the course of homologous desensitization from the
surface of tunicamycin-treated cells were already nonfunctional. Thus,
beta-adrenergic desensitization in tunicamycin-treated cells is
characterized by the functional disengagement of receptor removal and loss
of adenylate cyclase activity.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Oostendorp, D. S. Postma, H. Volders, H. Jongepier, H. F. Kauffman, H. M. Boezen, D. A. Meyers, E. R. Bleecker, S. A. Nelemans, J. Zaagsma, et al.
Differential Desensitization of Homozygous Haplotypes of the {beta}2-Adrenergic Receptor in Lymphocytes
Am. J. Respir. Crit. Care Med.,
August 1, 2005;
172(3):
322 - 328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Cumbay and V. J. Watts
Novel Regulatory Properties of Human Type 9 Adenylate Cyclase
J. Pharmacol. Exp. Ther.,
July 1, 2004;
310(1):
108 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Chotani, S. Flavahan, S. Mitra, D. Daunt, and N. A. Flavahan
Silent alpha 2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries
Am J Physiol Heart Circ Physiol,
April 1, 2000;
278(4):
H1075 - H1083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Izevbigie and W. G. Bergen
{beta}-Adrenergic Agonist Hyperplastic Effect Is Associated with Increased Fibronectin Gene Expression and Not Mitogen-Activated Protein Kinase Modulation in C2C12 Cells
Experimental Biology and Medicine,
March 1, 2000;
223(3):
302 - 309.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Schulte, R. Kurrle, M. Rollinghoff, and A. Gessner
Molecular Characterization and Functional Analysis of Murine Interleukin 4 Receptor Allotypes
J. Exp. Med.,
November 3, 1997;
186(9):
1419 - 1429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. da Silva Correia and R. J. Ulevitch
MD-2 and TLR4 N-Linked Glycosylations Are Important for a Functional Lipopolysaccharide Receptor
J. Biol. Chem.,
January 11, 2002;
277(3):
1845 - 1854.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|